The new mRNA vaccine from Moderna will enter final stages of testing within the next two weeks, with results so far showing it creates a “strong immune response”.

The world’s first norovirus vaccine is set to be trialled by the NHS in a bid to ease the strain on already stretched hospitals.

A new trial that aims to protect against norovirus, a highly contagious stomach bug that causes vomiting and diarrhoea, is set to be trialled on 25,000 people. Norovirus, commonly referred to as the “winter vomiting bug”, affects people of all ages and has had significant societal and healthcare impacts.

He said: “The UK is leading the way to develop a world-first vaccine for this vomiting bug, starting with this innovative vaccine trial delivered through the government-funded National Institute for Health and Care Research.

A vaccine is to be trialled on thousands of people to find out if it could protect against norovirus - a stomach bug that causes vomiting and diarrhoea. The easily spreadable winter virus can affect people of all ages and have huge consequences - often closing hospital wards,

World-first vaccine for vomiting bug norovirus trialled in the UK - The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.